Business Wire CSR | Business Wire | PR NewsWire | Marketwire | Realwire | ACN/JCN newswire | 247pressrelease | PRWeb | EmailWire | 3BLMedia | 1888PressRelease

Research and Markets: Belgium In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Posted : Thu, 19 Nov 2009 16:11:36 GMT
Author : Research and Markets
Category : Press Release
News Alerts by Email ( click here )
News | Home
DUBLIN - (Business Wire) Research and Markets (http://www.researchandmarkets.com/research/1a7472/belgium_in_vitro_d) has announced the addition of Global Markets Direct's new report "Belgium In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015" to their offering.

Belgium In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Belgium In vitro diagnostic devices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Belgium.

Scope

  • The report provides information on the Belgian in vitro diagnostics market, broken down into detailed categories and segments such as In Vitro Diagnostics, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology, Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.
  • Total revenues, end users
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Key Topics Covered:

  • 1 Contents
  • 2 Introduction
  • 3 Definitions of the Markets Covered in the Report
  • 4 Healthcare Sector Review
  • 5 Regulation System
  • 6 Pricing and Reimbursement
  • 7 Distribution Structure
  • 8 In Vitro Diagnostics In Belgium
  • 9 Clinical Chemistry In Belgium
  • 10 Genetic Testing In Belgium
  • 11 Haematology In Belgium
  • 12 Histology and Cytology In Belgium
  • 13 Immuno Chemistry In Belgium
  • 14 Infectious Immunology In Belgium
  • 15 Microbiology Culture In Belgium
  • 16 Overview of Key Companies in Belgium In Vitro Diagnostics Market
  • 17 Financial Deals Landscape
  • 18 Recent Developments
  • 19 Appendix
  • Executive Summary
  • List of Tables

For more information visit http://www.researchandmarkets.com/research/1a7472/belgium_in_vitro_d.

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Copyright © 2010 Business Wire. All rights reserved.
Share/Save/Bookmark

Article : Research and Markets: Belgium In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015
Print this article
Share this article

Stay Updated

News gadget on your Google homepage
Subscribe to a news feed in Google Reader



Related News



Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark
 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases

 
 

The Earth Times
News Category

© 2010 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.